Manmath Patekar
Impact in
- Immunology top 2%
- Psoriasis: Treatment and Pathogenesis
- Dermatology top 1%
- Dermatology and Skin Diseases
Papers in
- Immunology 17
- Psoriasis: Treatment and Pathogenesis 16
-
- Dermatology and Skin Diseases 9
- Co-authors
- Shephard Mpofu (3 shared papers)Iain B. McInnes (3 shared papers)Arthur Kavanaugh (2 shared papers)Hanno B. Richards (1 shared paper)R. Landewé (1 shared paper)Désirée van der Heijde (1 shared paper)Alice B. Gottlieb (2 shared papers)Proton Rahman (2 shared papers)
- Journals
- Journal of the American Academy of Dermatology (4 papers)Journal of the European Academy of Dermatology and Venereology (3 papers)Annals of the Rheumatic Diseases (2 papers)Pediatric Drugs (1 paper)Dermatologic Therapy (1 paper)
- Partner nations
- SwitzerlandUnited StatesChina
In The Last Decade
Manmath Patekar
19 papers receiving 1.1k citations
Manmath Patekar's Hit Papers
Peers
Comparison fields: 5 of 62
- Immunology 921
- Dermatology 358
- Hematology 396
- Rheumatology 513
- Pathology and Forensic Medicine 113
Countries citing papers authored by Manmath Patekar
This map shows the geographic impact of Manmath Patekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manmath Patekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manmath Patekar more than expected).
Fields of papers citing papers by Manmath Patekar
This network shows the impact of papers produced by Manmath Patekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manmath Patekar. The network helps show where Manmath Patekar may publish in the future.
Co-authors
The 25 scholars most cited alongside Manmath Patekar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2015 | 650 |
| 2 | 2018 | 144 | |
| 3 | 2018 | 65 | |
| 4 | 2020 | 60 | |
| 5 | 2020 | 44 | |
| 6 | 2020 | 32 | |
| 7 | 2021 | 28 | |
| 8 | 2019 | 20 | |
| 9 | 2021 | 13 | |
| 10 | 2022 | 11 | |
| 11 | 2023 | 7 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 5 | |
| 14 | 2023 | 5 | |
| 15 | 2015 | 4 | |
| 16 | 2021 | 3 | |
| 17 | 2021 | 2 | |
| 18 | 2021 | 1 | |
| 19 | 2015 | 1 | |
| 20 | 2023 | 0 |
About Manmath Patekar
Manmath Patekar is a scholar working on Immunology, Dermatology, Hematology, Rheumatology and Pediatrics, Perinatology and Child Health, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (16 papers), Dermatology and Skin Diseases (9 papers), Autoimmune and Inflammatory Disorders Research (9 papers), Pharmaceutical studies and practices (4 papers), Spondyloarthritis Studies and Treatments (3 papers), Autoimmune Bullous Skin Diseases (3 papers), Urticaria and Related Conditions (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). The work is most often cited by research in Immunology (921 citations), Dermatology (358 citations), Hematology (396 citations), Rheumatology (513 citations) and Pathology and Forensic Medicine (113 citations). Manmath Patekar has collaborated with scholars based in Switzerland, United States and China. Frequent co-authors include Shephard Mpofu, Iain B. McInnes, Arthur Kavanaugh, Hanno B. Richards, R. Landewé, Désirée van der Heijde, Alice B. Gottlieb, Proton Rahman, Philip G. Conaghan and Bruce Kirkham. Their work appears in journals such as Journal of the American Academy of Dermatology, Journal of the European Academy of Dermatology and Venereology, Annals of the Rheumatic Diseases, Pediatric Drugs and Dermatologic Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.